National and Kapodistrian University of Athens
Εκτίμηση της υποκλινικής αγγειοπάθειας με τη χρήση νεώτερων μη επεμβατικών αγγειακών βιοδεικτών σε ασθενείς με σακχαρώδη διαβήτη τύπου 2
Abstract
dc:descriptionBackground and aims: Diabetes is associated with higher incidence of cardiovascular complications due to accelerated arterial damage. The beneficial effect of multi-factorial treatment of cardiovascular risk factors (RFs) in type 2 diabetes is well established from randomized clinical trials. We prospectively examined the impact of such a treatment in a real-world setting, on the development of subclinical arterial damage (SAD), as determined by structural/functional non-invasive biomarkers of vascular pathology (atheromatosis [presence of atheromatous plaques in carotid/femoral arteries, ankle-brachial index], carotid hypertrophy [intima-media thickness, cross-sectional wall artery area], and arteriosclerosis [carotid-femoral pulse wave velocity, carotid distensibility]).Methods: We prospectively studied 116 persons with type 2 diabetes, treated with a multi-factorial approach of cardiovascular RFs in routine clinical practice at a tertiary medical center, and 324 individuals without diabetes, for 3.2 years. The primary outcome was changes in vascular biomarkers related to SAD.Results: At baseline, participants in the diabetes group had higher prevalence of subclinical arterial disease. At study end, changes in clinical, biochemical and lifestyle characteristics, as well as antihypertensive and lipid-lowering treatments, were comparable between the two groups. During follow-up, classical cardiovascular RFs (smoking, blood pressure, LDL-cholesterol, triglycerides), and behavioral features were significantly improved in both groups. Multivariate analysis, after adjusting for all classical cardiovascular RFs and use of anti-hypertensive/lipid-lowering therapies, demonstrated that all evaluated SAD biomarkers were similarly changed between the two groups.Conclusions: Implementation of a multi-modality approach of type 2 diabetes treatment is feasible and efficacious in decelerating progression rates of SAD in routine clinical practice.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Konstantonis, Georgios
- Κωνσταντώνης, Γεώργιος
Subjects
dc:subject × 14- Σακχαρώδης διαβήτης τύπου ΙΙ
- Υποκλινική αρτηριακή νόσος
- Καρδιαγγειακός κίνδυνος
- Αγγειακοί βιοδείκτες
- Diabetes type 2
- Subclinical arterial disease
- Cardiovascular risk
- Vascular biomarkers
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Καρδιολογία και Καρδιοαγγειακά νοσήματα
- Clinical Medicine
- Medical and Health Sciences
- Cardiology and Cardiovascular Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/49270